FREMONT, Calif., April 18, 2025 /PRNewswire/ -- On April 7, 2025, the U.S. Food and Drug Administration ("FDA" or "the agency"), classified Q'Apel Medical, Inc.'s ("Q'Apel" or "the company") voluntary recall of 1,617 units of its 072 Aspiration System (also known under the product name...
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Classifies Q'Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I )
Also on site :
- French leftists cry foul as Israel nixes visit
- Meeting with the Exporters and Investors Club
- Senior leaders are feeling the burden of cuts to middle management